title: Letter: the potential success of long-term therapy of chronic delta hepatitis with peginterferon alfa--authors' reply.
authors: Translational Hepatology Unit, Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA. kohchris@mail.nih.gov.
authors: C
authors: C
authors: Koh
authors: T
authors: T
authors: Heller
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D005260:Female; D006514:Hepatitis B Surface Antigens / Q000097:blood*; D019701:Hepatitis D, Chronic / Q000188:drug therapy*; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D008297:Male; D011092:Polyethylene Glycols / Q000627:therapeutic use*
chemical_list: D000998:Antiviral Agents; D006514:Hepatitis B Surface Antigens; D016898:Interferon-alpha; D011092:Polyethylene Glycols